[PDF][PDF] What is new in the 2017 World Health Organization classification and 8th American Joint Committee on Cancer staging system for pancreatic neuroendocrine …

J Choe, KW Kim, HJ Kim, DW Kim… - Korean journal of …, 2019 - synapse.koreamed.org
The diagnosis and management of pancreatic neuroendocrine neoplasms (NENs) have
evolved significantly in recent years. There are several diagnostic and therapeutic …

Targeted alpha particle therapy for neuroendocrine tumours: the next generation of peptide receptor radionuclide therapy

S Navalkissoor, A Grossman - Neuroendocrinology, 2019 - karger.com
Neuroendocrine tumours (NETs) are being seen increasingly frequently, but to date only
complete surgical resection is curative. However, among the various therapeutic options …

British Gynaecological Cancer Society (BGCS) cervical cancer guidelines: recommendations for practice

N Reed, J Balega, T Barwick, L Buckley… - European Journal of …, 2021 - Elsevier
Cervix cancer in many countries is declining and screening programmes and immunisation
will reduce the incidence in the next few decades. This guideline attempts to cover …

Update of the diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine …

B Kos-Kudła, W Foltyn, A Malczewska… - Endokrynologia …, 2022 - journals.viamedica.pl
Continuous progress in the diagnostics and treatment of neuroendocrine neoplasms
(NENs), the emerging results of new clinical trials, and the new guidelines issued by medical …

Neuroendocrine tumors and fibrosis: An unsolved mystery?

FM Laskaratos, K Rombouts, M Caplin… - Cancer, 2017 - Wiley Online Library
Neuroendocrine tumors are a heterogeneous group of slow‐growing neoplasms arising
mainly from the enterochromaffin cells of the digestive and respiratory tract. Although they …

Therapeutic options for neuroendocrine tumors: a systematic review and network meta-analysis

RM Kaderli, M Spanjol, A Kollár, L Bütikofer… - JAMA …, 2019 - jamanetwork.com
Importance Multiple therapies are currently available for patients with neuroendocrine
tumors (NETs), yet many therapies have not been compared head-to-head within …

Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours)

B Kos-Kudła, J Blicharz-Dorniak… - Endokrynologia …, 2017 - journals.viamedica.pl
Progress in the diagnostics and therapy of gastro-entero-pancreatic (GEP) neuroendocrine
neoplasms (NEN), the published results of new randomised clinical trials, and the new …

Prognostic role of lymph node positivity and number of lymph nodes needed for accurately staging small-bowel neuroendocrine tumors

MY Zaidi, AG Lopez-Aguiar, M Dillhoff, E Beal… - JAMA …, 2019 - jamanetwork.com
Importance Little information is available regarding the minimum number of lymph nodes
needed to accurately stage patients when performing a mesenteric lymphadenectomy for …

Peptide receptor radionuclide therapy with 90Y-DOTATATE/90Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: assessment of response …

S Vinjamuri, TM Gilbert, M Banks, G McKane… - British journal of …, 2013 - nature.com
Background: Peptide receptor radionuclide therapy (PRRT) is an established treatment for
patients with metastatic neuroendocrine tumours (NETs), although which factors are …

[HTML][HTML] Comparative analysis of international guidelines on the management of advanced non-functioning well-differentiated pancreatic neuroendocrine tumors

F Panzuto, A Lamarca, N Fazio - Cancer Treatment Reviews, 2024 - Elsevier
This review presents a comprehensive comparative analysis of international guidelines for
managing advanced, non-functioning, well-differentiated pancreatic neuroendocrine tumors …